|
ViziLite ® Plus oral lesion identification and marking system
The newest tool in the fight against oral disease is the ViziLite ® Plus oral lesion identification and marking system.
ViziLite ® Plus, from Zila Pharmaceuticals, combines the oral screening technology of ViziLite, an advanced chemiluminescent light technology to help detect oral abnormalities, with TBlue630T. TBlue630 is the only patented pharmaceutical-grade form of toluidine blue that has been cleared by the FDA for use in marking lesions identified during a ViziLite examination.
|